Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence - Report - MDSpire
Advertisement
Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence
Correction Notice: Identification of Unsupervised Risk Factors Across Various Cancer Types
Overview
Revise to focus solely on the typographical errors without additional implications.
Background
Accurate risk stratification is vital in oncology for effective clinical decision-making. The integration of artificial intelligence (AI) in cancer research has the potential to enhance diagnostic capabilities and improve patient outcomes. However, the reliability of AI models must be ensured through rigorous validation and correction of any errors in published data.
Data Highlights
No numerical or trial data is provided in the correction notice.
Key Findings
Typographical errors were identified in the axis labels of Figure 2b, Figure 2e, and Figure 3b.
The original article has been corrected to reflect accurate data representation.
Risk stratification methodologies often struggle to translate survival analyses into clinical guidelines.
AI systems can enhance diagnostic precision and detect patterns in oncology.
Regulatory guidance emphasizes the need for validation of AI models across cancer types.
Clinical Implications
Healthcare professionals should ensure that they reference corrected data in their clinical decision-making processes. Ongoing validation of AI models is essential to maintain trust in AI applications in oncology.
Conclusion
The correction notice highlights the importance of accuracy in published research, particularly in the context of AI applications in cancer care.
by Maximilian Ferle, Jonas Ader, Thomas Wiemers, Nora Grieb, Beatrice Berneck, Adrian Lindenmeyer, Hartmut Goldschmidt, Elias K. Mai, Uta Bertsch, Hans-Jonas Meyer, Thomas Neumuth, Markus Kreuz, Kristin Reiche, Maximilian Merz
